Huhtamaki Oyj (0K9W)
London Stock Exchange · UK · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 27.20 |
|---|---|
| 52-week range | 25.25 – 32.72 |
| Return, 1 month / 3 months | −8.1% / −8.4% |
| Return, 1 year / 3 years | −4.1% / −3.8% |
| Trend | Below its 200-day average |
| RSI (14) | 42 |
| Volatility (1 year) | 20.6% |
| Worst drawdown (1 year) | -17.6% |
| Average daily value traded | 1.06M EUR |
| Dividend yield | 4.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Huhtamaki Oyj is a packaging company based in Finland. It makes consumer packaging, including paper cups, food and beverage containers, moulded fibre products, films and labels, and flexible packaging. Its customers are mainly food and beverage brands, restaurant chains, retailers and consumer goods companies that need packaging for their products. The company also produces packaging for household and personal care items, and it operates manufacturing sites in many countries across Europe, the Americas and Asia.
The shares are listed on the London Stock Exchange in UK under the code 0K9W, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Huhtamaki Oyj (0K9W) trades on the London Stock Exchange in UK. It last closed at EUR 27.20 on 27 October 2026.
Its price-based Market X-Ray is 59 out of 100 (a fair price profile), ranking 1,447 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 4.1% and over the last three months it fell 8.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 51 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -3.3% | ||
| From 52-week high | -16.3% | ||
| Momentum | 47 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -8.4% | ||
| 6-month return | 5.9% | ||
| 12-month return, skipping the last month | 4.4% | ||
| Stability (higher is calmer) | 82 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 20.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.6% | ||
| Liquidity | 54 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.06M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 55 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.2% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +0.2% |
|---|---|
| 1 month | −8.1% |
| 3 months | −8.4% |
| 6 months | +5.9% |
| 1 year | −4.1% |
| 3 years | −3.8% |
| 5 years | −14.7% |
Signals
| 50-day / 200-day average | 29.10 / 28.14 |
|---|---|
| Golden / death cross (60 days) | Golden, 48 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.32 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Sep 2026 | EUR 0.5700 |
| 30 Apr 2026 | EUR 0.5700 |
| 30 Sep 2025 | EUR 0.5500 |
| 25 Apr 2025 | EUR 0.5500 |
| 30 Sep 2024 | EUR 0.5200 |
| 26 Apr 2024 | EUR 0.5300 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.